Українська
English
Search for:
Home
Fresh number
Archives
Authors
About Edition
Subscription
Requirements for publications
Review process
Actual
Clinical guidelines and recommendations
Clinical investigations
Events and Comments
History of medicine
International experience
Opinion
Original investigations
Own observations
Practitioner
Reviews
Magazine online
All news
Author : Bortkevych O.P.
DYNAMICS OF DEVELOPMENT OF CHONDROITIN SULFATE AND THE PLACE OF GLYCOSAMINOGLYCAN-PEPTIDE COMPLEXES IN THE TREATMENT OF OSTEOARTHRITIS
Authors: Dubkova A.G. Krylova A.S. Bortkevych O.P. Tsymbaliuk T.S. №83 (1) 2021 / Review: 59
HISTORY OF STUDYING OF SYSTEMIC DISEASES CONNECTIVE TISSUE AND SYSTEMIC VASCULITIS IN THE MIRROR OF NUMISMATICS
Authors: Syniachenko O.V. Kovalenko V. Bortkevych O.P. Gnylorybov A.M.... №81 (3) 2020 / Review: 113
Comorbidity: definition, possible ways to diagnostics and treatment
Authors: Kovalenko V. Bortkevych O.P. №77 (3) 2019 / Review: 77
ANCA-associated Vasculitidies — updated approach to patient management
Authors: Bortkevych O.P. Korendovych V.V. Yarets’ka G.V. №68 (2) 2017 / Review: 22
Efficacy of PIASKLEDIN® 300 in patients with primary knee and hip osteoarthritis
Authors: Bortkevych O.P. Korendovych V.V. Biliavska Iu.V. №66 (4) 2016 / Review: 31
Updated treatment approaches in the managment rheumatic patients during pregnancy and lactation
Authors: Bortkevych O.P. Biliavska Iu.V. Korendovych V.V. №64 (2) 2016 / Review: 21
Substantiation report concerning retention of diagnosis «Juvenile rheumatoid arthritis» status in adult patients with a disease onset in childhood and adolescence
Authors: Kovalenko V. Shuba N.M. Yaremenko O.B. Оmelchenko L.I.... №63 (1) 2016 / Review: 25
Piascledin® 300 efficacy in the management of osteoarthritis: proved in clinical trials, confirmed by European practice
Author:Bortkevych O.P. №59 (1) 2015 / Review: 12
The use of hyaluronic acid for the treatment of osteoarthritis
Authors: Kovalenko V.M. Bortkevych O.P. Boichuk N.S. №59 (1) 2015 / Review: 14
New strategy of rheumatoid arthritis therapy (on the base of 2013 update recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs)
Authors: Kovalenko V.M. Bortkevych O.P. Biliavska Yu. №54 (4) 2013 / Review: 18
BiologiC Drugs: WHAT’S the difference?
Authors: Kovalenko V.M. Bortkevych O.P. Rekalov D.H. Medvedchuk G.Y. №52 (2) 2013 / Review: 12
ACHIEVEMENTS TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: Kovalenko V.M. Golovach I.Yu. Bortkevych O.P. №50 (4) 2012 / Review: 18
CURRENT OBJECTIVES FOR TARGET TREATMENT OF RHEUMATOID ARTHRITIS: FROM MONOCLONAL ANTIBODIES TO BLOCKERS OF SIGNALING PATHWAYS MOLECULES
Authors: Kovalenko V.M. Golovach I.Yu. Bortkevych O.P. №49 (3) 2012 / Review: 13
SMOKING AND DEVELOPMENT OF RHEUMATOIS ARTHRITIS: PATHOGENETIC PUZZLES COMPLETION
Authors: Kovalenko V.M. Golovach I.Yu. Bortkevych O.P. №48 (2) 2012 / Review: 15
INDIVIDUALIZATION OF RHEUMATOID ARTHRITIS TREATMENT: COURSE TO ACHIEVE OPTIMUM RESULTS
Authors: Kovalenko V.M. Bortkevych O.P. №45 (3) 2011 / Review: 14
1
2
3
»